Variant report
Variant | esv12182 |
---|---|
Chromosome Location | chr2:114841889-114842770 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs55909031 | chr2:114841890-114841891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111334174 | chr2:114841898-114841899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201442102 | chr2:114841902-114841903 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs55846207 | chr2:114841916-114841917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532459540 | chr2:114841917-114841918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56076332 | chr2:114842004-114842005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374246304 | chr2:114842007-114842008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113697775 | chr2:114842024-114842025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113887661 | chr2:114842109-114842110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34303144 | chr2:114842113-114842114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113321735 | chr2:114842423-114842424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372198775 | chr2:114842489-114842490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113028313 | chr2:114842527-114842528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552469427 | chr2:114842592-114842593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs111801169 | chr2:114842631-114842632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112559789 | chr2:114842695-114842696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368736720 | chr2:114842704-114842705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113993190 | chr2:114842710-114842711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112979291 | chr2:114842735-114842736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556641105 | chr2:114842743-114842744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571692596 | chr2:114842758-114842759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:114840400-114842000 | Enhancers | Liver | Liver |
2 | chr2:114841400-114842800 | Weak transcription | HepG2 | liver |
3 | chr2:114842000-114842400 | Weak transcription | Liver | Liver |
4 | chr2:114842400-114843400 | Enhancers | Liver | Liver |